Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall SA, Gondek LP, Bashey A, Keyzner A, Tamari R, Grunwald MR, Abedin S, Nadiminti KV, Iqbal M, Gerds AT, Viswabandya A, McCurdy SR, Al Malki MM, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S. Jain T, et al. Among authors: viswabandya a. Haematologica. 2023 Dec 1;108(12):3321-3332. doi: 10.3324/haematol.2023.283426. Haematologica. 2023. PMID: 37408464 Free PMC article.
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.
Salas MQ, Atenafu EG, Lam W, Law AD, Kim DDH, Michelis FV, Al-Shaibani Z, Gerbitz A, Lipton JH, Viswabandya A, Mattsson J, Gupta V, Kumar R. Salas MQ, et al. Among authors: viswabandya a. Blood Cell Ther. 2020 Jul 14;3(3):48-58. doi: 10.31547/bct-2020-001. eCollection 2020 Aug 25. Blood Cell Ther. 2020. PMID: 36714178 Free PMC article.
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Kim KH, Kim T, Novitzky-Basso I, Lee H, Yoo Y, Ahn JS, Pasic I, Law A, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Mattsson J, Zhang Z, Kaushansky N, Brilon Y, Chapal-Ilani N, Biezuner T, Shlush LI, Kim DDH. Kim KH, et al. Among authors: viswabandya a. Haematologica. 2023 Jul 1;108(7):1817-1826. doi: 10.3324/haematol.2022.281806. Haematologica. 2023. PMID: 36727396 Free PMC article.
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Vasudevan Nampoothiri R, Tang K, Schuh A, Lam W, Maze D, Michelis FV, Chan S, Gupta V, Kim D, Kumar R, Lipton JH, Mattsson J, Minden M, Schimmer A, Sibai H, Viswabandya A, Yee K, Murphy T, Law AD. Vasudevan Nampoothiri R, et al. Among authors: viswabandya a. Eur J Haematol. 2023 Jun;110(6):618-625. doi: 10.1111/ejh.13940. Epub 2023 Feb 16. Eur J Haematol. 2023. PMID: 36732677
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.
Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall S, Gondek L, Bashey A, Keyzner A, Tamari R, Grunwald M, Abedin S, Nadiminti K, Iqbal M, Gerds A, Viswabandya A, McCurdy S, Malki MA, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S. Jain T, et al. Among authors: viswabandya a. Res Sq [Preprint]. 2023 Mar 21:rs.3.rs-2691216. doi: 10.21203/rs.3.rs-2691216/v1. Res Sq. 2023. PMID: 36993719 Free PMC article. Updated. Preprint.
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
Patel AA, Yoon JJ, Johnston H, Davidson MB, Shallis RM, Chen EC, Burkart M, Oh TS, Iyer SG, Madarang E, Muthiah C, Gross I, Dean R, Kassner J, Viswabandya A, Madero-Marroquin R, Rampal RK, Guru Murthy GS, Bradley TJ, Abaza Y, Garcia JS, Gupta V, Pettit KM, Cursio JF, Odenike O. Patel AA, et al. Among authors: viswabandya a. Blood Adv. 2024 May 13:bloodadvances.2024012880. doi: 10.1182/bloodadvances.2024012880. Online ahead of print. Blood Adv. 2024. PMID: 38739724
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor.
England JT, Atenafu EG, Kennedy JA, Goraya B, Cheung V, Nye T, Gauthier K, Davidson MB, Bankar A, Sibai H, Maze D, Viswabandya A, Gupta V. England JT, et al. Among authors: viswabandya a. Am J Hematol. 2023 May;98(5):E127-E129. doi: 10.1002/ajh.26890. Epub 2023 Mar 7. Am J Hematol. 2023. PMID: 36814403 Free article. No abstract available.
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Al-Shaibani E, Chen S, Chen C, Pasic I, Michelis FV, Lam W, Law A, Novitzky-Basso I, Gerbitz A, Kim DD, Viswabandya A, Lipton JH, Mattson J, Kumar R. Al-Shaibani E, et al. Among authors: viswabandya a. Ann Hematol. 2023 Apr;102(4):917-926. doi: 10.1007/s00277-023-05135-3. Epub 2023 Feb 23. Ann Hematol. 2023. PMID: 36820907
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Alfaro Moya T, Mattsson J, Remberger M, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Gerbitz A, Pasic I, Novitzky-Basso I, Michelis FV. Alfaro Moya T, et al. Among authors: viswabandya a. Eur J Haematol. 2023 Oct;111(4):553-561. doi: 10.1111/ejh.14041. Epub 2023 Jul 18. Eur J Haematol. 2023. PMID: 37461810
199 results